NCT05616754: A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) |
|
|
| Recruiting | 3 | 400 | RoW | Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel Coronavirus Protein Vaccine (CHO cells) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | COVID-19 | 07/23 | 09/23 | | |
NCT05859919: Conducting Clinical Trials of the Medicine "Rutan Tablets 0.1g" No. 10 in the Complex Therapy of COVID-19 |
|
|
| Completed | 2 | 57 | RoW | The drug "Rutan 0.1"., Rutan, Basic treatment | Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan | Patients With COVID-19 | 09/21 | 09/21 | | |
NCT05862883: Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVI |
|
|
| Completed | 2 | 301 | RoW | Rutan 25 mg, Rutan, Control group | Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan | COVID-19 Respiratory Infection | 07/22 | 07/22 | | |
